Transepithelial Customized Cross-linking
Study Details
Study Description
Brief Summary
Customized remodeled vision (CuRV) is a new corneal cross-linking protocol for keratoconus, combining a transepithelial approach with customized energy application. Our aim is to follow-up our patients and establish the short-and long-term results of CuRV.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
Customized remodeled vision is a protocol for oxygen-boosted, tranespithelial cross-linking, customized to apply higher energy at the apex of the cone, relatively lower to the cone area and none to healthy cornea. Thus CuRV promises to halt keratoconus progression, simultaneously offering potential for relatively good visual rehabilitation.Our primary outcomes involve spectacle-corrected distance visual acuity and changes in corneal topography/tomography and OCT parameters. These parameters include Kmax, thinnest corneal pachymetry, maximal anterior and posterior elevation, the Fourier analysis-derived irregularity index, and demarcation line depth.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Customized, transepithelial cross-linking All study patients will be treated according to the customized remodeled vision protocol |
Device: Cross-linking
Oxygen-boosted, epithelium-on, customized cross-linking. Highest UV-A application is focused on the apex of the cone. The cone area receives a moderate amount of UV-A, while healthy cornea is spared.
Other Names:
|
Outcome Measures
Primary Outcome Measures
- Spectacle-corrected distance visual acuity [1-3-6 months, 1 year, 2 years]
Measurements will be performed on Early Treatment of Diabetic Retinopathy Study charts in logMAR units
- Kmax [1-3-6 months, 1 year, 2 years]
Maximal corneal keratometric value measured on Scheimpflung corneal tomography
Secondary Outcome Measures
- Demarcation line depth [1 month]
Measurements will be performed at 1st postoperative month, when the demarcation line is most visible, on anterior segment optical coherence tomography. The measurement will be performed manually on the scan approximating the thinnest corneal location with the device-native caliper set at 1:1μm.
- Thinnest corneal pachymetry [1-3-6 months, 1 year, 2 years]
Values as indicated on Scheimpflung corneal tomography device
- Maximal anterior & posterior elevation [1-3-6 months, 1 year, 2 years]
Values as indicated on the Belin Ambrosio Enhanced Ectasia module of the Scheimpflung tomography device
- Fourier analysis-calculated maximum decentration [1-3-6 months, 1 year, 2 years]
Values as indicated on the Fourier analysis module of the Scheimpflung tomography device
- Regularization index [1-3-6 months, 1 year, 2 years]
Regularization index was proposed by Seiler et al. The measurement will be performed using the maximum flattening and steepening on the Comparison display of the Scheimpflung tomography device.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Topographic evidence of keratoconus:
-
maximum corneal curvature (Kmax) ≥47.00 D,
-
localized steepening on topographic maps,
-
localized elevation in the anterior and posterior corneal surfaces.
Exclusion Criteria:
-
Hypersensitivity to riboflavin
-
Thinnest corneal pachymetry < 380 μm
-
History of corneal surgery, including previous cross-linking
-
Corneal scarring
-
Aphakia
-
Pseudophakia
-
Any visually significant ocular condition
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Ophthalmica Eye Institute | Thessaloníki | Kalamaria | Greece | 54655 |
Sponsors and Collaborators
- Ophthalmica Eye Institute
Investigators
- Principal Investigator: Miltos Balidis, PhD, Ophthalmica Eye Institute
Study Documents (Full-Text)
None provided.More Information
Publications
- OphthalmicaEI